1.
N Engl J Med
; 387(16): 1524-1527, 2022 10 20.
Article
En
| MEDLINE
| ID: mdl-36130012
Antibodies , COVID-19 Vaccines , COVID-19 , Interleukin 1 Receptor Antagonist Protein , Myocarditis , Humans , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Interleukin 1 Receptor Antagonist Protein/immunology , Myocarditis/etiology , Myocarditis/immunology , SARS-CoV-2 , Vaccination